BackNucleotide Metabolism: Structure, Synthesis, and Disorders
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Nucleotide Metabolism
Overview
Nucleotide metabolism encompasses the synthesis, interconversion, and degradation of nucleotides, which are essential biomolecules for genetic information storage, energy transfer, and cellular signaling. This topic is fundamental in biochemistry, as it links molecular structure to cellular function and disease.
Importance of Nucleotides
Functions and Biological Roles
Building blocks of nucleic acids: Nucleotides are the monomeric units of DNA and RNA, essential for genetic information storage and transfer.
Components of coenzymes: Many coenzymes, such as coenzyme A and NAD+, contain nucleotide structures.
Energy currency: Nucleotides like ATP (adenosine triphosphate) are the primary energy carriers in cells.
Cell signaling: Cyclic nucleotides (e.g., cAMP) act as secondary messengers in signal transduction pathways.
Key Terms:
Nucleoside: Nitrogenous base + sugar
Nucleotide: Nitrogenous base + sugar + phosphate
Structure of Nucleotides and Nucleic Acids
Nitrogenous Bases
Pyrimidines: Single-ring structures; includes cytosine, thymine (in DNA), and uracil (in RNA).
Purines: Double-ring structures; includes adenine and guanine.
Examples:
Uracil: 2-oxy-4-oxy pyrimidine (found in RNA)
Thymine: 2-oxy-4-oxy-5-methyl pyrimidine (found in DNA)
Guanine: 2-amino-6-oxy purine
DNA vs. RNA: DNA contains deoxyribose sugar and thymine, while RNA contains ribose sugar and uracil.
Coenzymes and ATP
Role of Nucleotide-Derived Coenzymes
NAD+ (Nicotinamide adenine dinucleotide): Functions in redox reactions as an electron carrier.
Coenzyme A: Essential for acyl group transfer in metabolism.
ATP: Universal energy currency, providing energy for cellular processes.
Example: The hydrolysis of ATP to ADP and inorganic phosphate releases energy:
Synthesis of Nucleotides
De Novo and Salvage Pathways
De novo synthesis: Nucleotides are synthesized "from scratch" using small precursor molecules.
Salvage pathways: Nucleotides are recovered from dietary sources or the breakdown of nucleic acids.
Purine vs. Pyrimidine Synthesis: Purines are built onto a ribose-phosphate scaffold, while pyrimidines are synthesized as a ring and then attached to ribose-phosphate.
PURINE METABOLISM
De Novo Synthesis of Purines
Precursors: Glycine, glutamine, aspartate, CO2, and formyl-tetrahydrofolate contribute atoms to the purine ring.
Key intermediate: Inosine monophosphate (IMP) is the first purine nucleotide formed, which is then converted to AMP and GMP.
Pathway Summary:
Ribose-5-phosphate is converted to phosphoribosyl pyrophosphate (PRPP).
PRPP is aminated and built up to form IMP.
IMP is converted to AMP (adenosine monophosphate) and GMP (guanosine monophosphate).
Regulation of Purine Synthesis
Feedback inhibition: AMP and GMP inhibit their own synthesis at key regulatory steps.
PRPP synthetase and amidotransferase: These enzymes are regulated by end products to prevent overproduction.
Interconversion of Nucleotides
Nucleoside monophosphate kinases: Convert NMPs to NDPs (e.g., AMP + ATP → 2 ADP).
Nucleoside diphosphate kinase: Interconverts NDPs and NTPs (e.g., GDP + ATP ⇌ GTP + ADP).
Catabolism of Purines
Purine nucleotides are degraded to uric acid, which is excreted in urine.
Excess uric acid can lead to disorders such as gout.
PYRIMIDINE METABOLISM
De Novo Synthesis of Pyrimidines
Precursors: Aspartate and carbamoyl phosphate form the pyrimidine ring.
Key intermediates: Orotic acid is converted to UMP (uridine monophosphate).
UMP is phosphorylated to UDP and UTP; UTP can be aminated to CTP (cytidine triphosphate).
Thymidine Synthesis
Thymidylate synthase: Converts dUMP to dTMP, a key step for DNA synthesis.
Regulation: dTTP levels regulate the activity of ribonucleotide reductase and thymidylate synthase.
Catabolism of Pyrimidines
Pyrimidines are degraded to β-alanine and β-aminoisobutyrate, which are water-soluble and excreted.
Interconversion and Regulation of Deoxyribonucleotides
Key Enzymes and Pathways
Ribonucleotide reductase: Converts ribonucleotides (NDPs) to deoxyribonucleotides (dNDPs).
dNTP kinase: Converts dNDPs to dNTPs, which are substrates for DNA polymerases.
Thymidylate synthase: Converts dUMP to dTMP, essential for DNA synthesis.
Example Pathway:
dADP → dATP (via dNTP kinase)
dGDP → dGTP (via dNTP kinase)
dCDP → dCTP (via dNTP kinase)
dUDP → dTDP → dTTP (via dNTP kinase and thymidylate synthase)
Disorders of Nucleotide Metabolism
Gout and Hyperuricemia
Gout: Characterized by deposition of uric acid crystals in joints, causing pain and inflammation (often in the big toe).
Causes: Overproduction or reduced excretion of uric acid.
Treatment: Reduce intake of purine-rich foods, use of inhibitors (e.g., allopurinol), and supplementation as needed.
Lesch-Nyhan Syndrome
Genetic disorder: Caused by deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT).
Symptoms: Mental retardation, self-mutilation, gout-like symptoms due to increased uric acid.
Biochemical basis: Defective salvage pathway leads to increased de novo purine synthesis and uric acid production.
Cancer and Chemotherapy
Rapidly dividing cells: Cancer cells require increased nucleotide synthesis for DNA replication.
Chemotherapy: Drugs that inhibit nucleotide synthesis (e.g., methotrexate, 5-fluorouracil) are used to target cancer cells.
Summary Table: Key Enzymes in Nucleotide Metabolism
Enzyme | Function | Pathway |
|---|---|---|
Ribonucleotide reductase | Converts NDPs to dNDPs | Deoxyribonucleotide synthesis |
dNTP kinase | Converts dNDPs to dNTPs | Deoxyribonucleotide synthesis |
Thymidylate synthase | Converts dUMP to dTMP | Pyrimidine synthesis |
HGPRT | Salvages hypoxanthine and guanine | Purine salvage pathway |
Key Equations
Additional info:
Some diagrams and metabolic maps referenced in the slides are not fully reproduced here, but the main pathways and regulatory points are summarized above.
For further study, review the detailed mechanisms of enzyme regulation and the clinical implications of nucleotide metabolism disorders.